In patients with angina and no obstructive coronary artery disease (ANOCA), coronary vasospasm elicited by acetylcholine, regardless of phenotype, is associated with more-advanced atherosclerosis, ...

Acetylcholine (ACh) rechallenge may be a novel method to improve detection of coexisting coronary spasm endotypes, and at the same time, assess the treatment response to nitrate-based therapies, a new ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — In the first randomized trial of a therapy for treatment of patients with angina and nonobstructive ...

In a randomized trial of patients with angina and no obstructive coronary artery disease (ANOCA), 6 weeks of treatment with diltiazem did not improve coronary vasomotor dysfunction — apart from ...

The presence of epicardial coronary spasm and increased microvascular resistance in patients with angina but without obstructive coronary artery disease is associated with an increased risk of major ...

Myocardial infarction with nonobstructive coronary arteries (MINOCA) is a heterogeneous condition with diverse underlying causes, including atherosclerotic and nonatherosclerotic mechanisms. A ...